Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
Link opens in a new tab
English
Deutsch
Search content at Technical University of Munich
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Interleukin-6: Designing specific therapeutics for a complex cytokine
Christoph Garbers
, Sylvia Heink
,
Thomas Korn
, Stefan Rose-John
Chair of Experimental Neuroimmunology
Christian-Albrechts-University of Kiel
Technical University of Munich
Munich Cluster for Systems Neurology (SyNergy)
Research output
:
Contribution to journal
›
Review article
›
peer-review
540
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Interleukin-6: Designing specific therapeutics for a complex cytokine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Interleukin-6
100%
Interleukin-6 Signaling
100%
Clinical Trials
40%
Therapeutic Intervention
20%
Risk-benefit
20%
Dysregulation
20%
Signaling Pathway
20%
Patient Demographics
20%
Physiological Function
20%
Monoclonal Antibody
20%
Receptor-interacting Protein Kinase 1 (RIPK1)
20%
Inflammatory Disorders
20%
Rheumatoid Arthritis
20%
Interleukin-6 Receptor (IL-6R)
20%
Lymphoproliferative Disorders
20%
Autoimmune Disease Treatment
20%
Rheumatologic Diseases
20%
Castleman Disease
20%
IL-6 Blockade
20%
Immune Cell Proliferation
20%
Immune Cell Differentiation
20%
Janus Kinase Inhibitors
20%
Target Component
20%
Clinical Progress
20%
Trans-signaling Pathway
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Interleukin 6
100%
Clinical Trial
18%
Rheumatoid Arthritis
18%
Inflammatory Arthritis
18%
Diseases
18%
Interleukin 6 Receptor
9%
Lymphoproliferative Disease
9%
Monoclonal Antibody
9%
Autoimmune Disease
9%
Janus Kinase Inhibitor
9%
Angiofollicular Lymph Node Hyperplasia
9%
Immunology and Microbiology
Interleukin 6
100%
Cytokine
100%
Inflammatory Arthritis
18%
Signal Transduction
18%
Lymphoproliferative Disorders
9%
Castleman's Disease
9%
Cell Proliferation
9%
Cell Differentiation
9%
Immunocompetent Cell
9%
Autoimmune Disease
9%
Monoclonal Antibody
9%
Interleukin-6 Receptor
9%